Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple-negative Breast Cancer by a Novel Adenosine Monophosphate-activated Protein Kinase (AMPK) Activator
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple-negative Breast Cancer by a Novel Adenosine Monophosphate-activated Protein Kinase (AMPK) Activator
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 45, Pages 39247-39258
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2011-09-15
DOI
10.1074/jbc.m111.264598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adenosine 5'-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype
- (2014) D. Sag et al. JOURNAL OF IMMUNOLOGY
- AMPK and Akt Determine Apoptotic Cell Death following Perturbations of One-Carbon Metabolism by Regulating ER Stress in Acute Lymphoblastic Leukemia
- (2011) J. N. Kuznetsov et al. MOLECULAR CANCER THERAPEUTICS
- Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors
- (2011) E. Vilar et al. MOLECULAR CANCER THERAPEUTICS
- Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
- (2010) Mahvash Zakikhani et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
- (2010) R. M. Memmott et al. Cancer Prevention Research
- The ability of preoperative magnetic resonance imaging to predict actual pathologic tumor size in women with newly diagnosed breast cancer.
- (2010) L Vallow et al. CANCER RESEARCH
- New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK
- (2010) G. Zadra et al. CLINICAL CANCER RESEARCH
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
- (2010) M. Bodmer et al. DIABETES CARE
- AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3)
- (2010) A. Nerstedt et al. DIABETOLOGIA
- Regulation of mitochondrial biogenesis
- (2010) François R. Jornayvaz et al. Essays in Biochemistry
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Development of Novel Adenosine Monophosphate-Activated Protein Kinase Activators
- (2010) Jih-Hwa Guh et al. JOURNAL OF MEDICINAL CHEMISTRY
- AMP-activated protein kinase mediates activity-dependent regulation of peroxisome proliferator-activated receptor γ coactivator-1α and nuclear respiratory factor 1 expression in rat visual cortical neurons
- (2010) L. Yu et al. NEUROSCIENCE
- Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma
- (2010) Q.-W. Fan et al. Science Signaling
- AMP-activated protein kinase control of fat metabolism in skeletal muscle
- (2009) D. M. Thomson et al. Acta Physiologica
- Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids
- (2009) Yewei Ma et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
- (2009) Bei B. Zhang et al. Cell Metabolism
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- LKB1 and Mammalian Target of Rapamycin As Predictive Factors for the Anticancer Efficacy of Metformin
- (2009) Regan M. Memmott et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin in Breast Cancer: Time for Action
- (2009) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
- (2009) D. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Phosphorylation of LKB1 at Serine 428 by Protein Kinase C-ζ Is Required for Metformin-Enhanced Activation of the AMP-Activated Protein Kinase in Endothelial Cells
- (2008) Zhonglin Xie et al. CIRCULATION
- Targeting AMPK: A new therapeutic opportunity in breast cancer
- (2008) Sirwan M. Hadad et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Small Molecule Antagonizes Autoinhibition and Activates AMP-activated Protein Kinase in Cells
- (2008) Tao Pang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells
- (2008) Aina S. Lihn et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Direct regulation of TWIST by HIF-1α promotes metastasis
- (2008) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
- Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer
- (2007) Farhad Vesuna et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now